Literature DB >> 18262492

Casein Kinase I epsilon positively regulates the Akt pathway in breast cancer cell lines.

Cristina Modak1, Peter Bryant.   

Abstract

The Akt pathway is very important in both development and cancer. Here we show that, expression of Casein Kinase I epsilon (CKIepsilon) causes up-regulation of the Akt pathway despite normal protein expression of the pathway inhibitor phosphate and tensin homologue deleted on chromosome ten (PTEN). Conversely, we show that a CKIepsilon/delta-specific inhibitor can inhibit Akt phosphorylation at both Thr308 and Ser473 and drastically reduce phosphorylation of the Akt target Glycogen Synthase Kinase 3beta (GSK3beta). These conclusions were confirmed between MCF7 cells transiently transfected with CKIepsilon and Hs578T cells which already express endogenous CKIepsilon. The results suggest that CKIepsilon is a new positive regulator of the Akt pathway. Here we propose that, rather than inhibiting PTEN function, CKIepsilon positively regulates Akt possibly by inhibiting Protein Phosphatase 2A (PP2A).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18262492      PMCID: PMC2763534          DOI: 10.1016/j.bbrc.2008.02.001

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

Authors:  D D Sarbassov; David A Guertin; Siraj M Ali; David M Sabatini
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

2.  PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.

Authors:  L P Weng; W M Smith; P L Dahia; U Ziebold; E Gil; J A Lees; C Eng
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

3.  Differential distribution of protein phosphatase 2A in human breast carcinoma cell lines and its relation to estrogen receptor status.

Authors:  R Gopalakrishna; U Gundimeda; J A Fontana; R Clarke
Journal:  Cancer Lett       Date:  1999-03-01       Impact factor: 8.679

4.  Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.

Authors:  D R Alessi; S R James; C P Downes; A B Holmes; P R Gaffney; C B Reese; P Cohen
Journal:  Curr Biol       Date:  1997-04-01       Impact factor: 10.834

Review 5.  Regulation of protein kinase cascades by protein phosphatase 2A.

Authors:  T A Millward; S Zolnierowicz; B A Hemmings
Journal:  Trends Biochem Sci       Date:  1999-05       Impact factor: 13.807

Review 6.  AKT/PKB signaling mechanisms in cancer and chemoresistance.

Authors:  Donghwa Kim; Han C Dan; Sungman Park; Lin Yang; Qiyuan Liu; Satoshi Kaneko; Jinying Ning; Lili He; Hua Yang; Mei Sun; Santo V Nicosia; Jin Q Cheng
Journal:  Front Biosci       Date:  2005-01-01

7.  Structural insights into the regulation of PDK1 by phosphoinositides and inositol phosphates.

Authors:  David Komander; Alison Fairservice; Maria Deak; Gursant S Kular; Alan R Prescott; C Peter Downes; Stephen T Safrany; Dario R Alessi; Daan M F van Aalten
Journal:  EMBO J       Date:  2004-09-30       Impact factor: 11.598

8.  Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase.

Authors:  Jianhua Feng; Jongsun Park; Peter Cron; Daniel Hess; Brian A Hemmings
Journal:  J Biol Chem       Date:  2004-07-15       Impact factor: 5.157

9.  Somatic mutations and altered expression of the candidate tumor suppressors CSNK1 epsilon, DLG1, and EDD/hHYD in mammary ductal carcinoma.

Authors:  Tannin J Fuja; Fritz Lin; Kathryn E Osann; Peter J Bryant
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

10.  PTEN is destabilized by phosphorylation on Thr366.

Authors:  Helene Maccario; Nevin M Perera; Lindsay Davidson; C Peter Downes; Nick R Leslie
Journal:  Biochem J       Date:  2007-08-01       Impact factor: 3.857

View more
  6 in total

1.  Low cytoplasmic casein kinase 1 epsilon expression predicts poor prognosis in patients with hepatocellular carcinoma.

Authors:  Shu-Hui Lin; Chung-Min Yeh; Ming-Ju Hsieh; Yueh-Min Lin; Mei-Wen Chen; Chih-Jung Chen; Cheng-Yu Lin; Hsiao-Fang Hung; Kun-Tu Yeh; Shun-Fa Yang
Journal:  Tumour Biol       Date:  2015-10-20

Review 2.  Circadian rhythms in gene expression: Relationship to physiology, disease, drug disposition and drug action.

Authors:  Siddharth Sukumaran; Richard R Almon; Debra C DuBois; William J Jusko
Journal:  Adv Drug Deliv Rev       Date:  2010-06-11       Impact factor: 15.470

3.  Potential of casein kinase I in digestive cancer screening.

Authors:  Cristina Modak; Jianyuan Chai
Journal:  World J Gastrointest Oncol       Date:  2009-10-15

4.  ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth.

Authors:  Suping Zhang; Liguang Chen; Bing Cui; Han-Yu Chuang; Jianqiang Yu; Jessica Wang-Rodriguez; Li Tang; George Chen; Grzegorz W Basak; Thomas J Kipps
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

Review 5.  Targeting Casein Kinase 1 (CK1) in Hematological Cancers.

Authors:  Pavlína Janovská; Emmanuel Normant; Hari Miskin; Vítězslav Bryja
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

6.  Specific targeting of caspase-9/PP2A interaction as potential new anti-cancer therapy.

Authors:  Issam Arrouss; Fariba Nemati; Fernando Roncal; Marie Wislez; Karim Dorgham; David Vallerand; Nathalie Rabbe; Narjesse Karboul; Françoise Carlotti; Jeronimo Bravo; Dominique Mazier; Didier Decaudin; Angelita Rebollo
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.